Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Rating of “Hold” from Brokerages

Pediatrix Medical Group, Inc. (NYSE:MD) has earned an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $17.08.

A number of research analysts recently commented on the stock. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Truist Financial lifted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. Macquarie began coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Nomura Asset Management Co. Ltd. grew its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after buying an additional 1,040 shares in the last quarter. AlphaQuest LLC boosted its position in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares during the period. Smartleaf Asset Management LLC grew its stake in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock worth $91,000 after acquiring an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company’s stock worth $98,000 after acquiring an additional 5,104 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Up 6.4 %

Shares of MD opened at $14.12 on Thursday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.77, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $17.67. The business’s 50 day simple moving average is $14.35 and its 200-day simple moving average is $13.87.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. As a group, equities analysts expect that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.